Cambridge Antibody Technology Group plc (’CAT’) and Oxford Glycosciences plc (’OGS’)
(PR Newswire)
- YAHOO.COM
... significantly strengthened core capabilities in R&D by combining CAT’s leading human monoclonal antibody product development expertise with OGS’ oncology drug discovery capabilities and target pool...